News Anti-VEGF Efficacy in DME: Early Response Is Not Destiny by Medscape • 2019/01/23 • 0 Comments New data from Protocol T shows that eyes with poor 12-week response often had good vision at 2 years without switching therapies. Medscape Ophthalmology Full Story →